How do I buy Iterum Therapeutics (ITRM) stock?

You can purchase shares of Iterum Therapeutics (NASDAQ:ITRM) through any online brokerage.View our list of the best stock brokerages

Who are Iterum Therapeutics (ITRM) competitors?

Other companies in Iterum Therapeutics’s space includes: Gelteq Ltd (NASDAQ:GELS), Cocrystal Pharma Inc (NASDAQ:COCP), Addex Therapeutics Ltd (NASDAQ:ADXN), Kiora Pharmaceuticals Inc (NASDAQ:KPRX) and SCYNEXIS Inc (NASDAQ:SCYX).

What is the forecast, or price target, for Iterum Therapeutics (ITRM) stock?

Iterum Therapeutics has a consensus price target of $7.00.

What is the current price for Iterum Therapeutics (ITRM)?

The stock price for Iterum Therapeutics (NASDAQ: ITRM) is $0.35 last updated January 16, 2026 at 7:43 PM EST.

Does Iterum Therapeutics (ITRM) pay a dividend?

There are no upcoming dividends for Iterum Therapeutics.

When is Iterum Therapeutics (NASDAQ:ITRM) reporting earnings?

Iterum Therapeutics does not have any upcoming earnings scheduled.

Is Iterum Therapeutics (ITRM) going to split?

There is no upcoming split for Iterum Therapeutics.

What sector and industry does Iterum Therapeutics (ITRM) operate in?

Iterum Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Iterum Therapeutics (ITRM) Stock Price, Quote, News & History

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Pharmaceuticals

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem availabl...

Comments